Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fatty Acid Desaturases | 7 | 2020 | 48 | 1.060 |
Why?
|
| Phospholipases A | 13 | 2005 | 28 | 1.040 |
Why?
|
| Pulmonary Surfactants | 6 | 2012 | 15 | 0.860 |
Why?
|
| Neutrophils | 13 | 2016 | 118 | 0.830 |
Why?
|
| Fatty Acids, Omega-3 | 3 | 2017 | 56 | 0.740 |
Why?
|
| Asthma | 7 | 2021 | 438 | 0.730 |
Why?
|
| Arachidonic Acid | 9 | 2015 | 35 | 0.730 |
Why?
|
| Inflammation | 8 | 2020 | 542 | 0.650 |
Why?
|
| Phosphatidylglycerols | 4 | 2012 | 7 | 0.650 |
Why?
|
| Eosinophils | 5 | 2009 | 55 | 0.630 |
Why?
|
| Dietary Supplements | 2 | 2017 | 184 | 0.610 |
Why?
|
| Phospholipids | 2 | 2021 | 28 | 0.590 |
Why?
|
| Plant Oils | 3 | 2020 | 16 | 0.570 |
Why?
|
| Respiratory Distress Syndrome, Adult | 4 | 2015 | 55 | 0.550 |
Why?
|
| Fatty Acids, Omega-6 | 5 | 2017 | 29 | 0.510 |
Why?
|
| Linoleic Acid | 3 | 2020 | 16 | 0.460 |
Why?
|
| Multigene Family | 3 | 2018 | 51 | 0.440 |
Why?
|
| Phospholipases A2, Secretory | 1 | 2012 | 2 | 0.420 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 1 | 2011 | 1 | 0.410 |
Why?
|
| Group IA Phospholipases A2 | 1 | 2011 | 1 | 0.410 |
Why?
|
| Group IB Phospholipases A2 | 1 | 2011 | 1 | 0.410 |
Why?
|
| Dietary Fats | 2 | 2009 | 110 | 0.380 |
Why?
|
| Blood-Brain Barrier | 2 | 2020 | 50 | 0.360 |
Why?
|
| gamma-Linolenic Acid | 3 | 2020 | 9 | 0.340 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2020 | 35 | 0.340 |
Why?
|
| Hydrolysis | 6 | 2021 | 41 | 0.330 |
Why?
|
| Models, Biological | 2 | 2020 | 397 | 0.310 |
Why?
|
| Hyperlipidemias | 1 | 2008 | 54 | 0.300 |
Why?
|
| Humans | 39 | 2021 | 32297 | 0.290 |
Why?
|
| Bronchoalveolar Lavage Fluid | 5 | 2012 | 77 | 0.280 |
Why?
|
| Surface-Active Agents | 2 | 2021 | 5 | 0.260 |
Why?
|
| DNA Methylation | 2 | 2017 | 142 | 0.250 |
Why?
|
| Lung | 5 | 2004 | 262 | 0.240 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2020 | 1092 | 0.230 |
Why?
|
| Diet | 2 | 2017 | 384 | 0.220 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 4 | 1998 | 5 | 0.220 |
Why?
|
| Acute Lung Injury | 2 | 2015 | 32 | 0.220 |
Why?
|
| Inflammation Mediators | 2 | 2003 | 103 | 0.210 |
Why?
|
| Phospholipases A2 | 9 | 2005 | 22 | 0.210 |
Why?
|
| Diglycerides | 2 | 1998 | 4 | 0.200 |
Why?
|
| Organ Specificity | 2 | 2018 | 81 | 0.200 |
Why?
|
| Group X Phospholipases A2 | 1 | 2021 | 1 | 0.190 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2021 | 4 | 0.190 |
Why?
|
| Eicosanoids | 1 | 2021 | 8 | 0.190 |
Why?
|
| Gold | 1 | 2020 | 18 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2007 | 213 | 0.190 |
Why?
|
| Animals | 11 | 2016 | 7694 | 0.190 |
Why?
|
| Spheroids, Cellular | 1 | 2020 | 37 | 0.190 |
Why?
|
| Metal Nanoparticles | 1 | 2020 | 16 | 0.190 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 103 | 0.190 |
Why?
|
| alpha-Linolenic Acid | 2 | 2017 | 11 | 0.180 |
Why?
|
| Fluorescent Dyes | 1 | 2020 | 49 | 0.180 |
Why?
|
| Soybean Oil | 1 | 2020 | 7 | 0.180 |
Why?
|
| Metabolomics | 1 | 2020 | 53 | 0.180 |
Why?
|
| Sputum | 3 | 2021 | 43 | 0.180 |
Why?
|
| Respiratory Burst | 2 | 2016 | 3 | 0.180 |
Why?
|
| Epithelial Cells | 1 | 2000 | 149 | 0.170 |
Why?
|
| Enzyme Activation | 4 | 2009 | 135 | 0.170 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 154 | 0.170 |
Why?
|
| Organoids | 1 | 2020 | 94 | 0.170 |
Why?
|
| Flow Cytometry | 4 | 2016 | 187 | 0.170 |
Why?
|
| Dietary Fats, Unsaturated | 2 | 2009 | 26 | 0.160 |
Why?
|
| Phosphatidylcholines | 3 | 2011 | 21 | 0.160 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2017 | 23 | 0.150 |
Why?
|
| Quantitative Trait Loci | 1 | 2018 | 143 | 0.150 |
Why?
|
| Nutritional Status | 1 | 2017 | 73 | 0.150 |
Why?
|
| Neurons | 1 | 2020 | 413 | 0.140 |
Why?
|
| Lysophospholipids | 3 | 2005 | 24 | 0.140 |
Why?
|
| Docosahexaenoic Acids | 1 | 2015 | 20 | 0.130 |
Why?
|
| Temporal Lobe | 1 | 2015 | 34 | 0.130 |
Why?
|
| Liver | 2 | 2015 | 486 | 0.130 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 104 | 0.130 |
Why?
|
| Exercise | 1 | 2021 | 655 | 0.130 |
Why?
|
| Wasting Syndrome | 1 | 2015 | 14 | 0.130 |
Why?
|
| Physical Conditioning, Animal | 1 | 2015 | 32 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2016 | 247 | 0.120 |
Why?
|
| Group II Phospholipases A2 | 3 | 2003 | 3 | 0.110 |
Why?
|
| Cytosol | 5 | 2005 | 27 | 0.110 |
Why?
|
| Brain | 1 | 2020 | 971 | 0.110 |
Why?
|
| Genotype | 3 | 2020 | 742 | 0.110 |
Why?
|
| Exercise Therapy | 1 | 2015 | 259 | 0.110 |
Why?
|
| Bronchi | 2 | 2004 | 45 | 0.100 |
Why?
|
| Early Diagnosis | 1 | 2012 | 64 | 0.100 |
Why?
|
| Triglycerides | 2 | 2008 | 230 | 0.100 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2011 | 3 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 502 | 0.100 |
Why?
|
| Cattle | 1 | 2011 | 101 | 0.100 |
Why?
|
| Sheep | 1 | 2011 | 233 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 492 | 0.090 |
Why?
|
| Biological Transport | 2 | 2020 | 73 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 514 | 0.090 |
Why?
|
| Fatty Acids | 3 | 2009 | 97 | 0.090 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2009 | 4 | 0.080 |
Why?
|
| Acyltransferases | 1 | 2009 | 16 | 0.080 |
Why?
|
| Interleukin-5 | 1 | 2009 | 7 | 0.080 |
Why?
|
| Fish Oils | 1 | 2009 | 35 | 0.080 |
Why?
|
| Caspases | 1 | 2009 | 42 | 0.080 |
Why?
|
| Linseed Oil | 1 | 2008 | 2 | 0.080 |
Why?
|
| Echium | 1 | 2008 | 10 | 0.080 |
Why?
|
| Calgranulin A | 1 | 2007 | 3 | 0.080 |
Why?
|
| Calgranulin B | 1 | 2007 | 4 | 0.080 |
Why?
|
| S100 Proteins | 1 | 2007 | 19 | 0.080 |
Why?
|
| Cystic Fibrosis | 2 | 2007 | 24 | 0.080 |
Why?
|
| Lung Diseases | 1 | 2007 | 50 | 0.080 |
Why?
|
| HMGB1 Protein | 1 | 2007 | 4 | 0.070 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2007 | 10 | 0.070 |
Why?
|
| Granulocytes | 1 | 2007 | 17 | 0.070 |
Why?
|
| Oxygen | 2 | 1986 | 142 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 40 | 0.070 |
Why?
|
| Endotoxins | 1 | 2007 | 37 | 0.070 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2007 | 26 | 0.070 |
Why?
|
| Dexamethasone | 1 | 2007 | 44 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2008 | 701 | 0.070 |
Why?
|
| COS Cells | 3 | 2004 | 28 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2020 | 846 | 0.070 |
Why?
|
| Cholesterol | 1 | 2008 | 251 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 149 | 0.070 |
Why?
|
| Adult | 6 | 2021 | 9467 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2008 | 406 | 0.070 |
Why?
|
| Interleukin-1 | 1 | 2005 | 35 | 0.070 |
Why?
|
| Dinoprostone | 1 | 2005 | 34 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2007 | 161 | 0.070 |
Why?
|
| Muscle, Smooth | 1 | 2005 | 74 | 0.070 |
Why?
|
| Trachea | 1 | 2005 | 55 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 264 | 0.060 |
Why?
|
| Apoptosis | 1 | 2007 | 368 | 0.060 |
Why?
|
| Allergens | 1 | 2004 | 18 | 0.060 |
Why?
|
| Mucus | 1 | 2004 | 6 | 0.060 |
Why?
|
| Respiratory Mucosa | 1 | 2004 | 14 | 0.060 |
Why?
|
| Mucins | 1 | 2004 | 19 | 0.060 |
Why?
|
| European Continental Ancestry Group | 2 | 2020 | 1180 | 0.060 |
Why?
|
| Cell Line | 2 | 2007 | 462 | 0.060 |
Why?
|
| Kinetics | 2 | 2009 | 213 | 0.060 |
Why?
|
| Ribonucleases | 1 | 2003 | 4 | 0.060 |
Why?
|
| Young Adult | 2 | 2021 | 2626 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2007 | 534 | 0.060 |
Why?
|
| Male | 6 | 2021 | 19488 | 0.060 |
Why?
|
| Blood Proteins | 1 | 2003 | 19 | 0.060 |
Why?
|
| Substrate Specificity | 2 | 2000 | 90 | 0.060 |
Why?
|
| Saliva | 1 | 2003 | 36 | 0.050 |
Why?
|
| Transfection | 2 | 2000 | 202 | 0.050 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 1998 | 28 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2008 | 770 | 0.050 |
Why?
|
| Bronchoconstriction | 1 | 2021 | 3 | 0.050 |
Why?
|
| Osmotic Pressure | 1 | 2021 | 10 | 0.050 |
Why?
|
| Phosphorylation | 2 | 1998 | 234 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2000 | 40 | 0.050 |
Why?
|
| Pericytes | 1 | 2020 | 29 | 0.050 |
Why?
|
| Cell Membrane Permeability | 1 | 2020 | 19 | 0.050 |
Why?
|
| Histocytochemistry | 1 | 2000 | 32 | 0.050 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2020 | 13 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 76 | 0.050 |
Why?
|
| Adolescent | 3 | 2021 | 3571 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2000 | 62 | 0.050 |
Why?
|
| Female | 5 | 2021 | 20126 | 0.050 |
Why?
|
| Astrocytes | 1 | 2020 | 58 | 0.040 |
Why?
|
| Surface Tension | 3 | 2005 | 5 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 102 | 0.040 |
Why?
|
| Models, Immunological | 1 | 1999 | 9 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2020 | 187 | 0.040 |
Why?
|
| Synovial Fluid | 1 | 1998 | 8 | 0.040 |
Why?
|
| Lipids | 1 | 2020 | 226 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2020 | 550 | 0.040 |
Why?
|
| Cytokines | 1 | 2020 | 262 | 0.040 |
Why?
|
| Swine | 3 | 2005 | 216 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2020 | 230 | 0.040 |
Why?
|
| Lung Injury | 1 | 1999 | 66 | 0.040 |
Why?
|
| African Americans | 2 | 2017 | 1443 | 0.040 |
Why?
|
| Blotting, Western | 1 | 1998 | 305 | 0.040 |
Why?
|
| CpG Islands | 1 | 2017 | 46 | 0.040 |
Why?
|
| Protein Kinases | 1 | 1997 | 27 | 0.040 |
Why?
|
| Demography | 1 | 2017 | 109 | 0.040 |
Why?
|
| Cell Separation | 1 | 1998 | 94 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 136 | 0.040 |
Why?
|
| Biological Products | 1 | 1998 | 78 | 0.040 |
Why?
|
| Middle Aged | 3 | 2020 | 11949 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2016 | 76 | 0.030 |
Why?
|
| Phagocytes | 1 | 1995 | 5 | 0.030 |
Why?
|
| Blood Cells | 1 | 1995 | 9 | 0.030 |
Why?
|
| Mast Cells | 1 | 1995 | 18 | 0.030 |
Why?
|
| Sexual Maturation | 1 | 2015 | 35 | 0.030 |
Why?
|
| Superoxides | 1 | 1995 | 19 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 1832 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 268 | 0.030 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2015 | 9 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2015 | 24 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 2015 | 20 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2007 | 144 | 0.030 |
Why?
|
| Chemokines | 1 | 2015 | 38 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 35 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2015 | 59 | 0.030 |
Why?
|
| Aged | 2 | 2020 | 10398 | 0.030 |
Why?
|
| Muscular Atrophy | 1 | 2015 | 69 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 110 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 2274 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2014 | 192 | 0.030 |
Why?
|
| Hydrogen Peroxide | 2 | 1985 | 83 | 0.030 |
Why?
|
| Alleles | 1 | 2014 | 252 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2014 | 124 | 0.030 |
Why?
|
| Motor Activity | 1 | 2015 | 327 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 773 | 0.030 |
Why?
|
| Monocytes | 2 | 2007 | 126 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 1040 | 0.020 |
Why?
|
| Acute Disease | 2 | 2007 | 255 | 0.020 |
Why?
|
| Leukotriene B4 | 1 | 2009 | 3 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 2181 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2009 | 57 | 0.020 |
Why?
|
| Fluoresceins | 2 | 1986 | 8 | 0.020 |
Why?
|
| RNA | 1 | 2009 | 95 | 0.020 |
Why?
|
| Membrane Potentials | 2 | 1985 | 81 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2007 | 16 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 167 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2007 | 25 | 0.020 |
Why?
|
| Necrosis | 1 | 2007 | 56 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 117 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2007 | 248 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2007 | 142 | 0.020 |
Why?
|
| Microsomes | 1 | 2005 | 14 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 1133 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 3876 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2005 | 34 | 0.020 |
Why?
|
| Cyclooxygenase 1 | 1 | 2005 | 23 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 37 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 44 | 0.020 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 32 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2005 | 32 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 37 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 46 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2007 | 911 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1985 | 13 | 0.020 |
Why?
|
| Carbocyanines | 1 | 1985 | 3 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 176 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 1985 | 88 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2004 | 10 | 0.020 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2004 | 16 | 0.020 |
Why?
|
| Mucin-5B | 1 | 2004 | 3 | 0.010 |
Why?
|
| Bronchitis | 1 | 2004 | 2 | 0.010 |
Why?
|
| Mucin 5AC | 1 | 2004 | 3 | 0.010 |
Why?
|
| Sepsis | 1 | 1986 | 156 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 67 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2004 | 46 | 0.010 |
Why?
|
| Eosinophil Granule Proteins | 1 | 2003 | 1 | 0.010 |
Why?
|
| DNA | 1 | 2004 | 229 | 0.010 |
Why?
|
| Peroxidase | 2 | 1995 | 31 | 0.010 |
Why?
|
| Snake Venoms | 1 | 1998 | 2 | 0.010 |
Why?
|
| Mammals | 1 | 1998 | 11 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1998 | 10 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 258 | 0.010 |
Why?
|
| Pancreas | 1 | 1998 | 104 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1997 | 11 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 1997 | 5 | 0.010 |
Why?
|
| Child | 1 | 2004 | 2472 | 0.010 |
Why?
|
| Bronchial Provocation Tests | 1 | 1997 | 14 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 1997 | 122 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 1995 | 11 | 0.010 |
Why?
|
| Chemotactic Factors | 1 | 1995 | 4 | 0.010 |
Why?
|
| Cell Degranulation | 1 | 1995 | 4 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1995 | 22 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1995 | 41 | 0.010 |
Why?
|
| Cell Movement | 1 | 1995 | 171 | 0.010 |
Why?
|
| Macrophages | 1 | 1995 | 194 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 1986 | 6 | 0.000 |
Why?
|
| Permeability | 1 | 1986 | 9 | 0.000 |
Why?
|
| Binding, Competitive | 1 | 1986 | 37 | 0.000 |
Why?
|
| Extracellular Space | 1 | 1986 | 26 | 0.000 |
Why?
|
| Free Radicals | 1 | 1986 | 10 | 0.000 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1983 | 6 | 0.000 |
Why?
|